- Visibility 100 Views
- Downloads 24 Downloads
- DOI 10.18231/j.ijcbr.2020.024
-
CrossMark
Renal function impairment and HbA1c level in type 2 diabetes mellitus patients
Introduction
Type 2 diabetes has shown increase in both the prevalence and incidence globally especially in societies with economic transition like industrialized countries and developing countries.[1] The number of people suffering from diabetes has risen significantly, from 108 million in 1980 to 422 million in 2014. 8.5% in 2014.[2] Along with urbanization, people have developed of unhealthy lifestyle and dietary habits, which are considered to be the most important factors for the development of diabetes.[1] If diabetic patients remain undiagnosed or inadequately treated, which is the usual case, develop many chronic complications leading to several disability and even death. Risk of coronary heart disease and stroke is significantly high in diabetics than in the general population and even microvascular complications like diabetic nephropathy, retinopathy and neuropathy are also serious health problems which can deteriorate the quality of life and can lead to premature death.[1] Although the exact mechanism which is responsible for various cellular and organ dysfunction in DM is not clearly known, chronic hyperglycemia is considered an important etiological factor leading to complications.[3] The Diabetes Control and Complications Trial (DCCT) also showed that by achieving glycemic control close to the nondiabetic level by intervention can significantly reduced all the microvascular and complications of diabetes in type 1 DM.[4] For assessment of long-term glycemic control, estimation of glycated hemoglobin is the standard method. Consistently elevated plasma glucose leads to increase in nonenzymatic glycation of hemoglobin. As the average life span of red blood cell is 120 days, glycated hemoglobin gives idea about the glycemic control of previous 2–3 months.[3]
Diabetic nephropathy is one of the most common causes of chronic kidney disease (CKD) in India.[5] For staging of CKD, estimation of the glomerular filtration rate (GFR) is necessary. One of the commonly used equations to estimate GFR (eGFR) is equation from the Modification of Diet in Renal Disease (MDRD) study. This equation estimates GFR based on measured serum creatinine concentration, age, sex, and ethnic origin of an individual.[6]
Aims and Objective
This study was carried out to find association of glycemic control of type 2 diabetic patients with their renal impairment status, if any. HbA1c levels were estimated to know the glycemic control and they were compared with eGFR levels.
Materials and Methods
The study was carried out at Clinical Chemistry Laboratory of Biochemistry Department, S SG Hospital and Medical College, Baroda. Ethical Clearance was obtained from the Institutional Ethics Committee for Human Research. 50 patients of known cases of diabetes and 50 age and sex matched healthy individuals enrolled for the study after taking informed consent. They were divided into Group I -control group (n=50) consisted of age and sex matched persons coming to OPD for routine checkups or minor ailments and not having history of Diabetes Mellitus and Group II comprises known case of type -2 Diabetes Mellitus (n=50). Individuals who had recently (<3 months) received blood transfusion or donated blood, having active infections or pre-existing kidney disease and having haemoglobinopathies or bleeding disorder were excluded.
Study design
Informed consent of individuals included in the study was obtained for participation in study groups and for blood collection. Detailed medical history including personal history , present complaints and complication, past history , family history and treatment history was recorded.
Overnight fasting blood sample was collected in fluoride vacutainer (2 ml) for FBS, in EDTA vacutainer (2 ml) for HbA1c and in plain vacutainer (4 ml) for serum craetinine and other biochemical parameters. Serum or plasma separated within an hour and stored at 2-8° C temperature till analysis was done.
Estimation of serum creatinine was carried out by Modified Jaffe’s Kinetic method , plasma glucose by glucose oxidase - peroxidase method and HbA1c by turbidimetric immunoassay method. All estimations were carried out on Miura-300, fully automated biochemistry analyzer.
For estimation of GFR, Modification of Diet in Renal Disease (MDRD) equation was used. As per MDRD equation,
eGFR (mL/min per 1.73 m 2) = 186x (S.Creatinine)-1.154 x (Age in years) -0.203
for female : multiply by 0.742
for African Americans: multiply by 1.21
Statistical analysis
Statistical analysis was carried out using MedCalc version 19.1 (free trial version) and Microsoft Excel 2010. Student ’ s t-tests was used for comparisons. Value of p < 0.05 was take as statistically significant and p < 0.001 as statistically highly significant for all analysis. To assess correlation between different parameters regression correlation analysis was carried out.
Results
The study population consists of 50 type 2 DM patients and 50 controls. Gender distribution and average age in both groups is shown in Table 1.
| Group I (Controls) n=50 | Group II (T2DM) n=50 | |
| No. of Male | 29 | 26 |
| No. of Female | 21 | 24 |
| Age (Mean±SD) | 42.3±7.4 | 42.9±5.6 |
hows comparison of FBS, HbA1c, S.creatinine and eGFR in type 2 DM patients and control group. Average HbA1c and FBS values were higher in Type 2 DM patients and difference was highly significant (p<0.001). S.creatinine was significantly high in group II (p<0.05) and eGFR values were on lower side. The difference in eGFR values of both groups was highly significant (p<0.001).
| Group I (Controls) n=50 | Group II (T2DM) n=50 | p value | |||
| Mean | SD | Mean | SD | ||
| FBS (mg/dl) | 99.16 | 14.20 | 125.34 | 26.82 | <0.001 |
| HbA1c (%) | 5.59 | 0.61 | 7.78 | 1.63 | <0.001 |
| S. Creatinine (mg/dl) | 0.84 | 0.20 | 0.99 | 0.25 | <0.05 |
| eGFR (mL/min/1.73 m²) | 102.07 | 34.84 | 80.77 | 19.00 | <0.001 |
Correlation of FBS and HbA1c with eGFR was calculated using regression analysis ([Table 3]). Only in Group II (T2DM) significant negative correlation was found between HbA1c and eGFR( p< 0.001). [Figure 1] shows scatter plot for regression analysis between HbA1c and eGFR in Group II (T2DM).
| Group | Parameter | eGFR (mL/min/1.73 m²) | ||
| r | r2 | p value | ||
| Group I (Controls) | FBS (mg/dl) | -0.1025 | 0.0105 | 0.479 |
| HbA1c (%) | -0.1714 | 0.02938 | 0.234 | |
| Group II (T2DM) | FBS (mg/dl) | -0.0204 | 0.00042 | 0.888 |
| HbA1c (%) | -0.601 | 0.36119 | < 0.001 |
Discussion
Diabetic nephropathy is one of the common complications in d iabetic patients; around 20% to 30% of diabetic patient s develop diabetic nephropathy. Chronic hyperglycemia is important factor in development of nephropathy.[7] In controls we found mean HbA1c level 5.59 ± 0.61 which was significantly lower than that of Type 2 DM patients which was 7.78 ± 1.63. eGFR values, calculate using MDRD formula, were negatively related with HbA1c levels in Type 2 DM patients. Various studies have suggested increased risk of neuropathy, retinopathy and cardiovascular diseases with increase in HbA1c level in diabetic patients.[10], [9], [8] In a collaborative meta-analysis of 102 prospective studies, Emerging Risk Factors Collaboration concluded in diabetic patients risk of vascular diseases is related with their FBS is moderately, and relationship is non linear.[11] In our study we found no significant relationship of FBS with e GFR level.
Conclusion
Early identification of imminent complications like nephropathy in diabetic patients can definitely help in decreasing morbidity. HbA1c level in diabetic patients can significantly predict compromised renal function in diabetic patient, before alteration in serum creatinine levels. Regular monitoring of HbA1c level and changing treatment strategy based upon it, can delay the development of diabetic nephropathy.
Acknowledgement
We are also immensely grateful to Dr. H. B. Sirajwala, Associate Professor and Dr. Shilpa Jain, Professor and Head, Department of Biochemistry, Govt. Medical College Baroda, for insight and expertise they provided that greatly assisted the research.
Conflict of interest
None.
Source of funding
None.
References
- K Park, 23th edn.. Diabetes. Park's Textbook of Preventive and Social Medicine. 2015. [Google Scholar]
- . Who. Int 2019. [Google Scholar]
- A C Powers. Diabetes Mellitus: Complications. Harrison’s Principles of Internal Medicine. 2015. [Google Scholar]
- D M Natan. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study at 30 Years: Overview. Diabetes Care 2014. [Google Scholar]
- V Viswanathan. Type 2 diabetic nephropathy in India-magnitude of the problem. Nephrol Dial Transplant 1999. [Google Scholar]
- J M Bargman, K Skorecki. Chronic Kidney Disease. Harrison’s Principles of Internal Medicine. 2015. [Google Scholar]
- H Shahbazian, I Rezaii. Diabetic kidney disease; review of the current knowledge. J Renal Inj Prev 2013. [Google Scholar]
- J Su, L Zhao, X Zhang, H Cai, H Huang, F Xu. HbA1c variability and diabetic peripheral neuropathy in type 2 diabetic patients. Cardiovasc Diabetol 2018. [Google Scholar]
- Kay-Tee Khaw, Nicholas Wareham, Sheila Bingham, Robert Luben, Ailsa Welch, Nicholas Day. Association of Hemoglobin A1c with Cardiovascular Disease and Mortality in Adults: The European Prospective Investigation into Cancer in Norfolk. Ann Int Med 2004. [Google Scholar]
- Abd-Rashid Suraida, Mohtar Ibrahim, Embong Zunaina. Correlation of the anterior ocular segment biometry with HbA1c level in type 2 diabetes mellitus patients. PLOS ONE 2018. [Google Scholar] [Crossref]
- N Sarwar, P Gao, S R Seshasai, R Gobin, S Kaptoge, E D Angelantonio. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010. [Google Scholar]